|
TMEM69 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.678000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.564400E-02 |
| Normal-vs-Stage2 |
2.361200E-01 |
| Normal-vs-Stage3 |
2.921400E-01 |
| Normal-vs-Stage4 |
8.044200E-02 |
| Stage1-vs-Stage2 |
8.632200E-01 |
| Stage1-vs-Stage3 |
8.231000E-01 |
| Stage1-vs-Stage4 |
1.350610E-01 |
| Stage2-vs-Stage3 |
9.801000E-01 |
| Stage2-vs-Stage4 |
1.566240E-01 |
| Stage3-vs-Stage4 |
1.635650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.378400E-02 |
| Normal-vs-AfricanAmerican |
8.786300E-02 |
| Normal-vs-Asian |
7.400600E-03 |
| Caucasian-vs-AfricanAmerican |
9.128200E-01 |
| Caucasian-vs-Asian |
2.803600E-01 |
| AfricanAmerican-vs-Asian |
2.176200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.028400E-02 |
| Normal-vs-Female |
3.777200E-03 |
| Male-vs-Female |
8.174500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.272100E-02 |
| Normal-vs-Extreme_Weight |
3.177000E-01 |
| Normal-vs-Obese |
3.237000E-01 |
| Normal-vs-Extreme_Obese |
1.535040E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.073800E-01 |
| Normal_Weight-vs-Obese |
1.443020E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.932000E-01 |
| Extreme_Weight-vs-Obese |
9.002600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.716850E-01 |
| Obese-vs-Extreme_Obese |
2.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.82409999999989E-05 |
| Normal-vs-Age(41-60Yrs) |
2.520000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.985170E-01 |
| Normal-vs-Age(81-100Yrs) |
6.815200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.599570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.539900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.476000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.024000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.820300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.060200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.522100E-03 |
| Normal-VS-Type2 PRCC |
5.757400E-01 |
| Normal-VS-KIRP CIMP |
5.786200E-04 |
| Normal-VS-Unclassified PRCC |
2.886100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.788800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.036000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.529800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.504100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.082600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.833800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.195500E-02 |
| Normal-vs-N1 |
5.321900E-02 |
| Normal-vs-N2 |
1.984770E-01 |
| N0-vs-N1 |
2.242000E-01 |
| N0-vs-N2 |
4.638200E-02 |
| N1-vs-N2 |
6.112400E-01 |
|
|
